TipRanks
Go Ultimate55% OFF

RedHill Biopharma (2RH) Q1 2022 Earnings Report

5 Followers

DE:2RH Q1 2022 EPS Results

Actual EPS
-EUR 26.76
Consensus EPS
-EUR 267.62
Beat/Miss
Beat by +EUR 240.85
One Year Ago EPS
-EUR 446.03

DE:2RH Q1 2022 Revenue Results

Actual Revenue
EUR 16.30M
Expected Revenue
EUR 21.05M
Beat/Miss
Missed by -EUR 4.75M
YoY Revenue Growth
-10.25%

Earnings Announcement Details

Quarter
Q1 2022
Date
06/23/2022
Time
Before Open
Conference Call
Thursday, June 23, 2022
DE:2RH Upcoming Earnings

RedHill Biopharma's next earnings date is estimated for March 18, 2027, based on past reporting schedules.

Q1 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:2RH Earnings History

DE:2RH earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 18, 20272026 (Q4)―-―――
Sep 30, 20262026 (Q2)―-0.90-2.0756.56% (+1.17)
Apr 27, 20262025 (Q4)―-――
Sep 05, 20252025 (Q2)―-2.070―
May 13, 20252025 (Q1)―-――
Apr 10, 20252024 (Q4)―-――
Aug 29, 20242024 (Q2)―0.000.89-100.00% (-0.89)
May 07, 20242024 (Q1)―-――
Apr 08, 20242023 (Q4)―--0.04―
Nov 15, 20232023 (Q3)―0.04-2.14101.67% (+2.18)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed